Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Moschini

Showing results (501-510 of 561) with videos related to

Pageof 57
Sort By:
BJU International|July 9, 2025
Impact of timing of computed tomography staging and patient factors on the detection of 'true' cN+ bladder cancerMarkus von Deimling, Marc Furrer, Alberto Bianchi, et al.
European Urology|April 23, 2025
Bladder Preservation Strategies in Muscle-invasive Bladder Cancer: Recommendations from the International Bladder Cancer GroupShilpa Gupta, Patrick J Hensley, Roger Li, et al.
European Urology Open Science|May 15, 2023
Carboplatin Induction Chemotherapy in Clinically Lymph Node-positive Bladder CancerMarkus von Deimling, Laura S Mertens, Bas W G van Rhijn, et al.
Targeted Oncology|November 13, 2024
Adjuvant Immune Checkpoint Inhibitors for Muscle-Invasive Urothelial Carcinoma: An Updated Systematic Review, Meta-analysis, and Network Meta-analysisTakafumi Yanagisawa, Keiichiro Mori, Akihiro Matsukawa, et al.
Urologic Oncology|September 20, 2025
The influence of immunocompromised status on recurrence and progression free survival among nonmuscle invasive bladder cancers (NMIBCs) undergoing transurethral resection of bladder tumor (TURBT) and adjuvant intravesical bacillus Calmette Guerin (BCG): Analysis of USA insurance claim dataFrancesco Del Giudice, Valerio Santarelli, Jan Łaszkiewicz, et al.
Minerva Urology and Nephrology|January 13, 2021
A comparison of perioperative outcomes of laparoscopic versus open nephroureterectomy for upper tract urothelial carcinoma: a propensity score matching analysisLuca Afferi, Mohammad Abufaraj, Francesco Soria, et al.
BJU International|October 31, 2023
Impact of the extent of lymph node dissection on survival outcomes in clinically lymph node-positive bladder cancerMarkus von Deimling, Marc Furrer, Laura S Mertens, et al.
Journal of Clinical Medicine|October 20, 2020
Restaging Transurethral Resection of Bladder Tumours after BCG Immunotherapy Induction in Patients with T1 Non-Muscle-Invasive Bladder Cancer Might not Be Associated with Oncologic BenefitWojciech Krajewski, Marco Moschini, Łukasz Nowak, et al.
Urologic Oncology|November 18, 2018
Propensity-score-matched comparison of soft tissue surgical margins status between open and robotic-assisted radical cystectomyMarco Moschini, Francesco Soria, Romain Mathieu, et al.
Journal of Clinical Medicine|August 10, 2019
Open Versus Robotic Cystectomy: A Propensity Score Matched Analysis Comparing Survival OutcomesMarco Moschini, Stefania Zamboni, Francesco Soria, et al.
Pageof 57

Showing results (501-510 of 561) with videos related to

Sort By:
Pageof 57
BJU International|July 9, 2025
Impact of timing of computed tomography staging and patient factors on the detection of 'true' cN+ bladder cancerMarkus von Deimling, Marc Furrer, Alberto Bianchi, et al.
European Urology|April 23, 2025
Bladder Preservation Strategies in Muscle-invasive Bladder Cancer: Recommendations from the International Bladder Cancer GroupShilpa Gupta, Patrick J Hensley, Roger Li, et al.
European Urology Open Science|May 15, 2023
Carboplatin Induction Chemotherapy in Clinically Lymph Node-positive Bladder CancerMarkus von Deimling, Laura S Mertens, Bas W G van Rhijn, et al.
Targeted Oncology|November 13, 2024
Adjuvant Immune Checkpoint Inhibitors for Muscle-Invasive Urothelial Carcinoma: An Updated Systematic Review, Meta-analysis, and Network Meta-analysisTakafumi Yanagisawa, Keiichiro Mori, Akihiro Matsukawa, et al.
Urologic Oncology|September 20, 2025
The influence of immunocompromised status on recurrence and progression free survival among nonmuscle invasive bladder cancers (NMIBCs) undergoing transurethral resection of bladder tumor (TURBT) and adjuvant intravesical bacillus Calmette Guerin (BCG): Analysis of USA insurance claim dataFrancesco Del Giudice, Valerio Santarelli, Jan Łaszkiewicz, et al.
Minerva Urology and Nephrology|January 13, 2021
A comparison of perioperative outcomes of laparoscopic versus open nephroureterectomy for upper tract urothelial carcinoma: a propensity score matching analysisLuca Afferi, Mohammad Abufaraj, Francesco Soria, et al.
BJU International|October 31, 2023
Impact of the extent of lymph node dissection on survival outcomes in clinically lymph node-positive bladder cancerMarkus von Deimling, Marc Furrer, Laura S Mertens, et al.
Journal of Clinical Medicine|October 20, 2020
Restaging Transurethral Resection of Bladder Tumours after BCG Immunotherapy Induction in Patients with T1 Non-Muscle-Invasive Bladder Cancer Might not Be Associated with Oncologic BenefitWojciech Krajewski, Marco Moschini, Łukasz Nowak, et al.
Urologic Oncology|November 18, 2018
Propensity-score-matched comparison of soft tissue surgical margins status between open and robotic-assisted radical cystectomyMarco Moschini, Francesco Soria, Romain Mathieu, et al.
Journal of Clinical Medicine|August 10, 2019
Open Versus Robotic Cystectomy: A Propensity Score Matched Analysis Comparing Survival OutcomesMarco Moschini, Stefania Zamboni, Francesco Soria, et al.
Pageof 57